The rapid spread of the
Delta variant of the coronavirus has only ratcheted up the pressure.
That variant, first identified in India, accounted for 51.7% of all new Covid-19 infections in the country over the two weeks that ended Saturday, the US Centers for Disease Control and Prevention
has estimated.
"We should think about the
Delta variant as the 2020 version of Covid-19 on steroids," Andy Slavitt, a former senior adviser to Joe Biden's Covid Response Team, told CNN on Wednesday. "It's twice as infectious. Fortunately, unlike 2020, we actually have a tool that stops the Delta variant in its tracks: It's called vaccine."
For fully vaccinated people, the variant "presents very little threat to you, very unlikely that you're gonna get sick," he explained.
Full approval for vaccines from the US Food and Drug Administration could encourage more people to get vaccinated, Slavitt and other experts have said. The current vaccines distributed in the US are authorized for emergency use only. Full approval for the Pfizer vaccine could come as early as this month, Slavitt said Tuesday.
As of Wednesday, less than half of the US population -- 47.6% -- was
fully vaccinated. The percentage of eligible people who were fully vaccinated -- ages 12 and up -- was 55.6%.
The case rate has been rising for the US as a whole. The country has averaged more than 15,060 new cases a day over the last week -- 20.7% higher than the average from the week prior, according to Johns Hopkins data.
The average is still well below this spring's peak -- an average of 71,320 daily for a week ending April 14 -- and the pandemic peak average of more than 251,000 daily for a week ending January 8.
In a grim reminder of the scale of the pandemic, the global death toll from Covid-19 has reached more than 4 million,
data from Johns Hopkins on Wednesday showed.
Three countries account for more than a third of all global deaths. The US, which has the highest number of fatalities at 606,000, accounts for 15% of the global total, followed by Brazil and India.
Underscoring vaccines' effectiveness, researchers say the American toll would have been a lot worse without inoculations.
The US would have seen about 279,000 more Covid-19 deaths by June 28 had vaccinations -- which first became available in December -- not have taken place,
according to researchers at Yale University and the Commonwealth Fund. The country also would have seen as many as 1.25 million additional hospitalizations, the researchers said.
Fears about more variants if people don't get vaccinated
But the Delta variant is not the only one worrying health experts.
"Right now, you want to look at who's getting sick, whether from the Delta variant or any other variant: It's people who haven't been vaccinated," Dr. Megan Ranney told CNN on Wednesday.
"I don't want it to come to this, but I am hopeful that these surges will drive more people in those states with low vaccination rates to finally go out and get their shot."
Vaccinated people don't have much to worry about, said
Ranney, an emergency physician at Rhode Island Hospital and an associate professor at Brown University.
But she offered an unsettling insight on the current surge of cases.
"What worries me more are the variants yet to come. And every time this virus is passed from one person to another, it has a chance to mutate. And it's only a matter of time until we have a variant against which the vaccines no longer protect us," she explained.
Some
experts have begun asking whether it may be time to start testing vaccinated people to ensure the Delta variant does not evade the effects of vaccines.
Current federal guidelines say fully vaccinated people can refrain from routine testing. Studies and experts have also said the vaccines are still highly protective.
"I think now we should revisit this policy with the Delta variant and determine if the current recommendations hold up," Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, wrote in an email to CNN on Wednesday.
The CDC is only reporting data on "breakthrough" infections that cause severe disease. That could mean scientists and health officials will not know how many vaccinated people have mild or asymptomatic infections -- and it will be very difficult to track whether a new variant such as Delta is causing more vaccine failure.